GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

European Commission approves GSK’s fully liquid Menveo meningococcal vaccine: London, UK Friday, November 29, 2024, 11:00 Hrs [IST] GSK plc announced that the European Commissio ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

Per GSK, a potential approval of this 5-in-1 vaccine candidate could provide the broadest meningococcal serogroup coverage and lead to a simplified immunization schedule. The 5-in-1 meningitis ...

GSK) today announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (Meningococcal Group A, C, W-135 and Y conjugate vaccine, MenACWY vaccine ...

GSK's liquid meningitis vaccine, Menveo, received approval from ... supports simplifying the vaccination process against invasive meningococcal disease, or IMD, as it offers healthcare providers ...

Through immunization programs, numerous countries throughout the world are actively promoting meningococcal vaccine. For instance, GSK plc reported promising findings for the MenABCWY combination ...